noImage

반려동물 감염병 신속 진단 시스템 개발 추진
Industry-academic development of fast diagnostic kit for infectious animal diseases agreed JNU Veterinary Teaching Hospital and Genesystem agreed on the platform’s clinical use

Jeju National University Veterinary Teaching Hospital and Genesystem agreed to develop a fast diagnostic system for infectious animal diseases, the university’s animal hospital announced Tuesday (April 27).

Under the agreement, the animal hospital will develop a fast diagnostic kit for infectious animal diseases that can be used in veterinary clinics and verify the kit’s accuracy through clinical evaluation.

Genesystem, Korea’s emerging biotechnology leader, will commercialize the fast diagnostic platform and distribute it to the markets in Korea and overseas.

Genesystem develops molecular testing platforms, targeting on-site testing needs. The company’s innovative technology features both the speed of immunodiagnostics and the accuracy of molecular diagnostics for which the technology has recently held the limelight amid the COVID-19 pandemic.

Using the company’s technology, the molecular diagnostic process now takes no more than 30 minutes, which otherwise would take two or more hours. On top of that, the testing procedures have become simpler when compared to those of the previous technology, requiring no complicated steps such as extracting nucleic acid and handling reagents.

Accordingly, it is expected that Genesystem’s testing platform will allow for a faster and more convenient diagnosis of infectious animal diseases in the disease testing centers and clinics.

During the signing ceremony, Yoon Young-min, director of JNU Veterinary Teaching Hospital, pointed out that Jeju Island serve as an “outpost” where Korea’s climatic and environmental changes can be estimated. He added that the island’s environment is helpful for a preemptive study on the diagnostic technologies related to infectious animal diseases which may spread across the Korean Peninsula in the future. Using Genesystem’s advanced platform and the university hospital’s clinical testing effectively, a highly valuable diagnostic system will be able to be developed and commercialized, he predicted.

Seo Yujin, CEO of Genesystem, assured that a diagnostic kit for practical use in clinical fields will be successfully developed, given the expertise of the JNU animal hospital which has conducted different research projects using Genesystem’s platform technology. He also stressed that his company will use the agreement as an opportunity to diversify its portfolio to include the field of animal disease diagnostics, ultimately entering the related global market ealier than expected.